Completed PHASE3 INTERVENTIONAL 2-arm NCT06381076

High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.

Examining the Impact of High-protein Oral Supplement With Liposomal Curcumin on Inflammation Markers and Oxidative Stress in Adults Undergoing Hemodialysis.

Sponsor: University of Florida

Conditions Chronic Kidney Disease 5D

Interventions Food colorant Liposomal curcumin

Updated 7 times since 2024 Last updated: Aug 1, 2025 Started: Feb 3, 2025 Primary completion: May 13, 2025 Completion: May 13, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Chronic Kidney Disease 5D, this trial is completed. The trial is conducted by University of Florida and has accumulated 7 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3

Status: Recruiting → Completed
Mar 2025 — Sep 2025 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Nov 2024 — Mar 2025 [monthly]

Not Yet Recruiting PHASE3

Phase: NA → PHASE3
Oct 2024 — Nov 2024 [monthly]

Not Yet Recruiting NA
Sep 2024 — Oct 2024 [monthly]

Not Yet Recruiting NA

▶ Show 2 earlier versions

Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
May 2024 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Florida

Data source: University of Florida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gainesville, United States